FDA
-
-
-
-
-
-
-
Cellectar Biosciences raises up to $140 million in oversubscribed financing
-
-
-
-
-
-
-
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
-
-
-
-
-
-
-
Cellectar Biosciences presents pancreatic cancer drug data at AACR conference
-
-
-
-
-
-
-
Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)
-
-
-
-
-
-
-
Cellectar Biosciences (CLRB) and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
-
-
-
-
-
-
-
Cellectar Biosciences (CLRB) Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules
-
-
-
-
-
-
-
Cellectar Biosciences (CLRB) to Explore Strategic Alternatives
-
322,199 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

